Detailed information for compound 1874008

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 586.764 | Formula: C35H46N4O4
  • H donors: 2 H acceptors: 3 LogP: 4.4 Rotable bonds: 13
    Rule of 5 violations (Lipinski): 2
  • SMILES: OC[C@@H](N1C[C@H](C)[C@H](CN(Cc2ccc(cc2)c2ccccc2)C)Oc2c(C1=O)cc(cc2)NC(=O)CCCN(C)C)C
  • InChi: 1S/C35H46N4O4/c1-25-21-39(26(2)24-40)35(42)31-20-30(36-34(41)12-9-19-37(3)4)17-18-32(31)43-33(25)23-38(5)22-27-13-15-29(16-14-27)28-10-7-6-8-11-28/h6-8,10-11,13-18,20,25-26,33,40H,9,12,19,21-24H2,1-5H3,(H,36,41)/t25-,26-,33-/m0/s1


Hover on a compound node to display the structore


No synonyms found for this compound


Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Loa Loa (eye worm) leukotriene A4 hydrolase 0.0091 0.995 0.5
Trypanosoma cruzi cytosolic leucyl aminopeptidase, putative 0.0054 0 0.5
Toxoplasma gondii leucyl aminopeptidase LAP 0.0092 1 0.5
Trypanosoma brucei metallo-peptidase, Clan MF, Family M17 0.0054 0 0.5
Echinococcus multilocularis leucine aminopeptidase protein 0.0092 1 1
Leishmania major cytosolic leucyl aminopeptidase,metallo-peptidase, Clan MF, Family M17 0.0054 0 0.5
Brugia malayi hypothetical protein 0.0082 0.7411 0.5
Schistosoma mansoni leukotriene A4 hydrolase (M01 family) 0.0091 0.995 0.5
Wolbachia endosymbiont of Brugia malayi leucyl aminopeptidase 0.0092 1 0.5
Trypanosoma cruzi metallo-peptidase, Clan MF, Family M17, putative 0.0054 0 0.5
Mycobacterium tuberculosis Probable aminopeptidase PepB 0.0092 1 0.5
Mycobacterium leprae Probable cytosol aminopeptidase PepB 0.0092 1 0.5
Echinococcus granulosus leucine aminopeptidase protein 0.0092 1 1
Plasmodium falciparum M17 leucyl aminopeptidase 0.0054 0 0.5
Mycobacterium ulcerans leucyl aminopeptidase 0.0092 1 0.5
Plasmodium vivax M17 leucyl aminopeptidase, putative 0.0092 1 0.5


No activities found for this compound.


Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.